#disease is an active hashtag on Bluesky. In the last 30 days, 106 people shared 601 posts with it — around 20 a day. Activity is down 13% versus the previous week, peaking on Jul 20 with 32 posts.
Tags most often used together with #disease.
www.jezebel.com
Congrats to RFK Jr., As the U.S. Is Poised to Lose Its Measles Elimination Status After 25 Years
After a quarter century where measles was considered eliminated in the U.S., 2025's continuous outbreaks have us back at ground zero.
www.jezebel.com
There Have Already Been More 2026 Measles Cases in the U.S. Than 2023 and 2024 Combined
In the first three weeks of 2026, there have already been more than 400 new measles cases, as the U.S. looks to blow past 2025's highs.
media.tenor.com
garfield is laying in a box with the words `` nap time '' .
ALT: garfield is laying in a box with the words `` nap time '' .
www.who.int
Third meeting of the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for Bundibugyo virus disease outbreak response: meeting report, 31 July 2026
This meeting report summarizes the deliberations and recommendations of the WHO Technical Advisory Group on Candidate Vaccine Prioritization (TAG-CVP) regarding candidate vaccines for the rapidly evol...
www.nature.com
Brain-derived neurotrophic factor (BDNF) in neonatal blood: associations with respiratory disease in extremely preterm infants
Neurotrophins, including brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4), have been associated with the development of bronchopulmonary dysplasia (BPD) in preterm infants. Objectives To evaluate relationships between early postnatal BDNF and NT-4 levels and adverse pulmonary outcomes among preterm infants. Methods We analyzed data from the Extremely Low Gestational Age Newborn (ELGAN) cohort. Serum BDNF and NT-4 were measured at birth and postnatal days 7, 14, 21, and 28. Pulmonary outcomes included BPD and early respiratory patterns predictive of BPD, specifically, pulmonary deterioration (PD) and early and persistent pulmonary dysfunction (EPPD). Associations were evaluated using regression models adjusted for perinatal confounders. Results NT-4 levels were not associated with BPD risk. Persistently high BDNF trajectories were associated with reduced risk, while persistently low BDNF was associated with increased risk of BPD, PD, and EPPD (BPD: OR 2.75; 95% CI 1.83-4.15; PD: OR 3.13; 95% CI 1.60–6.14; and EPPD: OR 7.94; 95% CI 3.70–17.04). Infants with persistently low and intermediate BDNF trajectories had higher risk of adverse pulmonary outcomes compared with those with persistently high BDNF levels. Conclusions Longitudinal BDNF trajectories identify subgroups of preterm infants at differential risk for adverse respiratory outcomes. Persistently high BDNF during the first month of life...
www.downtoearth.org.in
Africa's Greater Horn region is facing a looming polycrisis fueled by conflict, prices, climate and disease
The impacts of astrengthening El Niño and the lingering effects of thewar in Iran highlight two separate and seemingly unrelated global hazards. But in the Greater Horn of Africa, an area alreadybeset by prolonged crisis and conflict, these factors are combining with others to potentially create a major, multicountry polycrisis. Asexperts in famine,conflictandhumanitariancrises, our concerns about such a grave risk for the region in the second half of 2026 and into 2027 are based on a series of overlapping trends that include El Niño, the broader effects on food prices and fertilizer of the Iran war, internal conflicts and other localized factors. We fear the consequences could be catastrophic. Several factors underpin this risk. First, the short rains in the eastern Greater Horn of Africa — parts of Somalia, eastern Kenya, eastern Ethiopia — were well below average in thefall of 2025. The long rains inMarch to May of 2026 were alsowell below normal for much of that area, affecting both crops production and grazing and water for livestock, deepening the crisis of rural livelihoods. The regional forecast for the northern Horn of Africa, where for the most part there is only one rainy season per year, is also projected...
www.zmescience.com
8 Diseases You Won't Believe Are Still Plaguing the World
A disease can vanish from public memory long before it vanishes from the world. That gap, between what society remembers and what microbes continue to do, has allowed some of humanity’s oldest killers to survive in the present tense. We have the medicine to deal with them, but they persist because protection remains uneven, fragile, and easy to withdraw. We’ve selected a few striking examples. These are diseases you might imagine as artifacts — names from medieval chronicles, colonial records and old vaccination posters. But they never disappeared. They still infect people, still exploit weak health systems and, in some places, still kill people. 1. Leprosy For centuries, societies treated people with leprosy as threats to be expelled rather than patients to be treated. The disease appears in ancient writings, religious traditions and some of history’s most enduring images of illness and exclusion. That stigma has proved as hard to tackle as the infection itself. Leprosy, also called Hansen’s disease, remains present in more than 120 countries. It’s caused by a bacterial infection and remains remarkably prevalent. Health authorities reported 172,717 new cases in 2024, including 9,397 among children. India, Brazil and Indonesia are some of the countries with the...
www.nature.com
The dynamic spectrum of steatotic liver disease: the global perspective
Addison, T. Observations on fatty degeneration of the liver. Guys Hosp. Rep. 1, 476–485 (1836). Ayonrinde, O. T. Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD — reconciling the present with the past. JHEP Rep. 3, 100261 (2021). Ludwig, J., Viggiano, T. R., McGill, D. B. & Ott, B. J. Nonalcoholic fatty liver disease: pathologic findings and clinical correlations. Mayo Clin. Proc. 73, 434–438 (1998). Younossi, Z. M. et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod. Pathol. 11, 560–565 (1998). Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116, 1413–1419 (1999). Schaffner, F. & Thaler, H. Nonalcoholic fatty liver disease. Prog. Liver Dis. 8, 283–298 (1986). Eslam, M., Sanyal, A. J. & George, J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 158, 1999–2014 (2020). Younossi, Z. M. et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology 73, 1194–1198 (2021). Younossi, Z. M. et al. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology 76, 1423–1437 (2022). Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty...
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.
